Company intelligence / Profile preview

Strata Medical Innovations

Lubbock, Texas, United Statesfacebook.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company's flagship product, Hand Held Nitrous (HHN), delivers nitrous oxide via a pocket-sized inhaler to provide approximately five minutes of pain and anxiety relief. It has regulatory approval in Canada and Australia. U.S. FDA clearance and European CE mark are pending or recently obtained for some certifications. No clinical trial results are publicly detailed.

Therapeutic areas: OtherPsychiatryDermatology
Modalities: DeviceInhaled gas therapy (nitrous oxide)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Hand Held Nitrous

Commercial

Indications: Anxiety, Procedural pain

Partnerships

None specifically listed; seeking global distributors for the device.

Beyond the preview

Go deeper on Strata Medical Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strata Medical Innovations.

Explore the full profile